Asahi-Seiki Manufacturing Co.,Ltd. (XNGO:6111)

Oncternal Therapeutics Revenue

Asahi-Seiki Manufacturing had revenue of 2.43B JPY in the quarter ending June 30, 2025, with 29.29% growth. This brings the company's revenue in the last twelve months to 12.32B, up 0.09% year-over-year. In the fiscal year ending March 31, 2025, Asahi-Seiki Manufacturing had annual revenue of 11.77B, down -10.46%.

• Revenue (ttm): 12.32B
• Revenue Growth: +0.09%
• P/S Ratio: 0.41
• Revenue / Employee: 25.83M
• Employees: 477
• Market Cap: 5.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	11.77B	-1.38B	-10.46%
Mar 31, 2024	13.14B	43.00M	0.33%
Mar 31, 2023	13.10B	181.00M	1.40%
Mar 31, 2022	12.92B	1.16B	9.89%
Mar 31, 2021	11.76B	-2.19B	-15.67%